Senolytics are compounds that selectively eliminate senescent cells, sometimes called zombie cells. These are cells that have stopped dividing but remain metabolically active, secreting pro-inflammatory signals that accumulate in tissues over time. Clearing them is being studied as a potential approach to reducing chronic inflammation associated with aging.

Should women use quercetin supplements as a senolytic?

Mayo Clinic researchers caution against using commercial quercetin as an anti-aging senolytic without first knowing your individual senescent cell burden. The study found that in women, senolytic action may interfere with natural transient repair mechanisms, a risk that does not apply to general antioxidant supplementation at standard doses.

Why do women and men respond differently to senolytics?

Women appear to retain more active transient senescence, a process where damaged cells temporarily pause and enter a senescent-like state to coordinate repair before resuming function. Senolytics that remove these cells may disrupt repair. In men, this transient mechanism is more often already diminished, so senolytics tend to target genuinely dormant cells.

Quercetin Senolytics Work Differently in Women, Mayo Clinic Finds

Senescent cells, the ones researchers call zombie cells, do not divide and do not die. They sit in tissue and continuously release inflammatory signals that accumulate over years, contributing to chronic low-grade inflammation associated with age-related decline.

Senolytics are compounds designed to clear them. And quercetin, a flavonoid found in apples, onions, and capers, has become one of the most discussed natural candidates in this space.

The first RCT in healthy aging women

Mayo Clinic published results from a phase 2 randomized controlled trial testing senolytics in 60 healthy postmenopausal women over 20 weeks. The protocol used an intermittent dosing approach combining dasatinib, a prescription cancer drug, with quercetin. This was the first RCT to test senolytic therapy specifically in healthy older women, rather than patients with a diagnosed condition.

The trial aimed to understand whether the cellular benefits observed in earlier animal and preclinical studies would translate to human aging in this population.

Sex-dependent differences: what was found

The headline finding was that senolytic response is not uniform across sexes. In female participants, quercetin appeared to interfere with what researchers describe as transient senescence, a temporary state cells enter following damage to coordinate repair before resuming normal function.

In women, this transient repair mechanism appeared more intact compared to men of similar age. When senolytics clear cells in this temporary repair state alongside permanently senescent ones, the outcome may be counterproductive, removing cells that were still performing a function.

In men, the transient repair mechanism is more commonly already compromised at older ages, meaning senolytic treatment is more likely to selectively remove cells that have genuinely lost function. The net benefit calculation shifts accordingly.

Mayo Clinic’s guidance on commercial supplements

The research team was direct: do not use commercial quercetin supplements for anti-aging purposes without understanding your individual senescent cell burden. The reasoning is that without knowing the ratio of truly dormant zombie cells to cells in transient repair states, it is not possible to predict whether senolytic action will help or interfere.

This is not a concern about quercetin at standard dietary or supplemental doses for antioxidant or anti-inflammatory purposes. It is specific to using quercetin at senolytic doses with the explicit goal of clearing aging cells.

The measurement problem

The gap in this field is diagnostic. Senescent cell burden, meaning how many of these cells you carry and where, cannot currently be measured with routine clinical tests. Research tools exist, but they are not part of standard wellness evaluations.

Until that gap closes, the population-level finding that women and men respond differently still cannot be applied at the individual level with precision. The field is building toward personalized senolytic protocols but has not yet arrived.

What this means for longevity-focused consumers

Quercetin remains a well-researched flavonoid with real anti-inflammatory and antioxidant evidence. What this study changes is the framing around high-dose senolytic use, particularly for postmenopausal women. The expectation that more clearance of aging cells is always better does not hold up against this data.

For women incorporating longevity-focused supplementation, the more relevant question this study surfaces is not which supplement to take but what your current cellular environment actually looks like.

What are senolytics? Compounds that selectively clear senescent (zombie) cells, which secrete chronic inflammatory signals without dividing or dying. Reducing their accumulation is a major focus of longevity research.

Should women use quercetin as a senolytic? Mayo Clinic researchers advise against it without knowing individual senescent cell burden. In women, senolytics may interfere with transient repair senescence, clearing cells that are still functional.

Why do sexes respond differently? Women retain more active transient senescence (a repair mechanism) at older ages. Senolytics targeting this state may disrupt cellular repair. In men, this mechanism is more often already lost, making senolytic clearance more selectively beneficial.

Source: Mayo Clinic News Network